Iron Horse Therapeutics, Inc.

Iron Horse Therapeutics, Inc. is a life-Science company, focus on identification and development of therapeutic drug candidate for tthe treatment of amyotrophic lateral sclerosis (ALS).

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Website
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address
LA Jolla,CA,92037
San Diego
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]

In Nov 2015, Iron Horse Therapeutics, acquired an exclusive rights to develop small molecule inhibitors of EPH receptor A4 (EPHA4) from Sanford Burnham Prebys Medical Discovery Institute.

In Nov 2015, Iron Horse Therapeutics, Inc. recieved $ 10 Mn series A funding from the GlaxoSmithKline and Avalon Ventures.